Concepedia

Koen Hens

KH

Statistics

Publications

6

Citations

266

H-Index

6

Active since

1991

Affiliations

Janssen (Belgium)(Current)

Koen Hens is an author at Janssen (Belgium) specializing in medicine, antibiotics, and clinical microbiology.

Top concepts

Publications per year

1991–2014

6

Publications

6

Sigma metrics used to assess analytical quality of clinical chemistry assays: importance of the allowable total error (TEa) target

Koen Hens, Mario Berth, Dave Armbruster et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2014 · 102 citations

Discovery of a New Series of Centrally Active Tricyclic Isoxazoles Combining Serotonin (5-HT) Reuptake Inhibition with α<sub>2</sub>-Adrenoceptor Blocking Activity

José Ignacio Andrés, Jesús Alcázar, José Manuel Alonso Segura et al. · Journal of Medicinal Chemistry · 2004 · 49 citations · Full text

, , +16

JNJ-40255293, a Novel Adenosine A<sub>2A</sub>/A<sub>1</sub>Antagonist with Efficacy in Preclinical Models of Parkinson’s Disease

John Atack, Brian C. Shook, Stefanie Rassnick et al. · ACS Chemical Neuroscience · 2014 · 41 citations

Pharmacology of JNJ-42314415, a Centrally Active Phosphodiesterase 10A (PDE10A) Inhibitor: A Comparison of PDE10A Inhibitors with D2 Receptor Blockers as Potential Antipsychotic Drugs

Anton Megens, Herman M. R. Hendrickx, Koen Hens et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 36 citations

Pharmacological Profile of (2 R-trans)-4-[1-[3,5-bis(Trifluoromethyl)benzoyl]-2-(phenylmethyl)-4-piperidinyl]-N-(2,6-dimethylphenyl)-1-acetamide (S)-Hydroxybutanedioate (R116301), an Orally and Centrally Active Neurokinin-1 Receptor Antagonist

Anton A. H. P. Megens, D. Ashton, Jef Vermeire et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 26 citations

1–5 of 6